Using Twitter as an Intelligence Tool: 85 Accounts Worth Following image

Regulatory Affairs, November 16, 2017
Zachary Brennan, citing Twitter accounts of Rachel E. Sachs (Academic Fellow Alumna), Ameet Sarpatwari, Aaron Kesselheim and Amitabh Chandra (Affilia


Read the Full Article

With the rise of president-elect Donald Trump, it’s become abundantly clear that Twitter matters. And it matters not just for politics. For regulatory affairs folks in in the pharmaceutical and medical device spaces, for investors, and even for the regulators themselves, Twitter is a great place to catch the day’s breaking news before the headlines are written.


Academics and Doctors and Lawyers and Lawyer/Doctor Academics

These are the folks who write and publish journal articles on all things health and pharmaceutical/medical device policy. They are also often quoted in news stories, raising red flags and offering justifiable opinions without turning the conversation into what Twitter all too often becomes: A shouting match with anonymous trolls.

  1. Ameet Sarpatwari, instructor at Harvard Medical School
  2. Jacob Sherkow, associate professor at New York Law School
  3. Scott Gottlieb, physician, former FDA official and AEI fellow
  4. Vinay Prasad, assistant professor of medicine at Oregon Health and Sciences University
  5. Joseph Ross, primary care physician and health policy researcher at Yale
  6. Matthew Herder, associate professor at Dalhousie University
  7. Elaine Blais, patent litigator at Goodwin Procter
  8. Aaron Kesselheim, associate professor of medicine at Harvard Medical School
  9. Hank Greely, Stanford University law professor
  10. Eric Topol, Director of Scripps Translational Science Institute
  11. Walid Gellad, co-director of the Pittsburgh Center for Pharmaceutical Policy & Prescribing
  12. Nicolas Terry, health law professor at Indiana University
  13. Rachel Sachs, associate professor of law at Washington University in St. Louis
  14. Siddhartha Mukherjee, cancer physician, researcher and author
  15. Peter Bach, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering
  16. Amitabh Chandra, professor at Harvard Kennedy School 
  17. [...]

See the full list here.

bioethics biotechnology fda health law policy pharmaceuticals rachel sachs regulation